126 related articles for article (PubMed ID: 38364650)
1. Integrated bioinformatics approaches and expression assays identified new markers in pituitary adenomas.
Motlagh PE; Jamali E; Karimi N; Eslami S; Sharifi G; Ghafouri-Fard S
Pathol Res Pract; 2024 Mar; 255():155193. PubMed ID: 38364650
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.
Butz H; Likó I; Czirják S; Igaz P; Korbonits M; Rácz K; Patócs A
Pituitary; 2011 Jun; 14(2):112-24. PubMed ID: 21063788
[TBL] [Abstract][Full Text] [Related]
3. A bioinformatics-based approach and expression assay for identification of dysregulated genes in pituitary adenoma.
Jamali E; Hashemnejad MA; Askari A; Shomali H; Eslami S; Akbari Dilmaghani N; Sharifi G; Bahranian A; Ghafouri-Fard S
Pathol Res Pract; 2024 Jan; 253():155006. PubMed ID: 38056134
[TBL] [Abstract][Full Text] [Related]
4. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the expression of necroptosis pathway mediators and its association with tumor characteristics in functional and non-functional pituitary adenomas.
Khamseh ME; Sheikhi A; Shahsavari Z; Ghorbani M; Akbari H; Imani M; Panahi M; Alimohammadi A; Ameri M; Nazem S; Salimi V; Tavakoli-Yaraki M
BMC Endocr Disord; 2022 Jan; 22(1):1. PubMed ID: 34983494
[TBL] [Abstract][Full Text] [Related]
6. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
7. A novel risk model based on the correlation between the expression of basement membrane genes and immune infiltration to predict the invasiveness of pituitary adenomas.
Chen Z; Sun X; Kang Y; Zhang J; Jia F; Liu X; Zhu H
Front Endocrinol (Lausanne); 2022; 13():1079777. PubMed ID: 36686480
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-Inducible Factor 1α and AT-Rich Interactive Domain-Containing Protein 1A Expression in Pituitary Adenomas: Association with Pathological, Clinical, and Radiological Features.
Kinali B; Senoglu M; Karadag FK; Karadag A; Middlebrooks EH; Oksuz P; Sandal E; Turk C; Diniz G
World Neurosurg; 2019 Jan; 121():e716-e722. PubMed ID: 30292665
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas.
Shao S; Li X
J Neurosurg Sci; 2013 Sep; 57(3):267-75. PubMed ID: 23877272
[TBL] [Abstract][Full Text] [Related]
10. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
[TBL] [Abstract][Full Text] [Related]
11. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
Dai C; Liang S; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
[TBL] [Abstract][Full Text] [Related]
12. Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas.
Zhu H; Guo J; Shen Y; Dong W; Gao H; Miao Y; Li C; Zhang Y
Clin Cancer Res; 2018 Nov; 24(22):5757-5766. PubMed ID: 29980532
[No Abstract] [Full Text] [Related]
13. Expression pattern of lncRNAs in pituitary adenomas.
Ghafouri-Fard S; Khaledabadi M; Najafi G; Safarzadeh A; Hussen BM; Eslami S; Sharifi G; Taheri M; Dilmaghani NA
Pathol Res Pract; 2023 Aug; 248():154668. PubMed ID: 37418994
[TBL] [Abstract][Full Text] [Related]
14. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.
Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR
PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of functioning and non-functioning pituitary adenomas.
Qin J; Li K; Wang X; Bao Y
Medicine (Baltimore); 2021 Apr; 100(14):e25306. PubMed ID: 33832102
[TBL] [Abstract][Full Text] [Related]
16. Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.
Chile T; Corrêa-Giannella ML; Fortes MA; Bronstein MD; Cunha-Neto MB; Giannella-Neto D; Giorgi RR
J Endocrinol Invest; 2011 Sep; 34(8):e214-8. PubMed ID: 21270509
[TBL] [Abstract][Full Text] [Related]
17. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK
Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271
[TBL] [Abstract][Full Text] [Related]
18. Patterns of extrasellar invasive growth of pituitary adenomas with normal sellar cavity size.
Sharifi G; Sabahi M; Amin A; Dilmaghani NA; Nejad AM; Davoudi Z; Mohajeri-Tehrani M; Rezaei O; Borghei-Razavi H
Clin Neurol Neurosurg; 2021 Oct; 209():106942. PubMed ID: 34547643
[TBL] [Abstract][Full Text] [Related]
19. Decreased TAp63 and ΔNp63 mRNA Levels in Most Human Pituitary Adenomas Are Correlated with Notch3/Jagged1 Relative Expression.
Mezzomo LC; Pesce FG; Marçal JM; Haag T; Ferreira NP; Lima JF; Leães CG; Oliveira MC; da Fonte Kohek MB
Endocr Pathol; 2017 Mar; 28(1):13-21. PubMed ID: 28078618
[TBL] [Abstract][Full Text] [Related]
20. Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue.
Peculis R; Mandrika I; Petrovska R; Dortane R; Megnis K; Nazarovs J; Balcere I; Stukens J; Konrade I; Pirags V; Klovins J; Rovite V
Front Endocrinol (Lausanne); 2020; 11():313. PubMed ID: 32528411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
